What is the share price of ANG Lifesciences India Ltd (ANG) today?
The share price of ANG as on 11th March 2025 is ₹31.89. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on ANG Lifesciences India Ltd (ANG) share?
The past returns of ANG Lifesciences India Ltd (ANG) share are- Past 1 week: -5.39%
- Past 1 month: -17.89%
- Past 3 months: -31.77%
- Past 6 months: -43.05%
- Past 1 year: -45.65%
- Past 3 years: -82.75%
- Past 5 years: 146.14%
What are the peers or stocks similar to ANG Lifesciences India Ltd (ANG)?
The peers or stocks similar to ANG Lifesciences India Ltd (ANG) include:What is the market cap of ANG Lifesciences India Ltd (ANG) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of ANG Lifesciences India Ltd (ANG) is ₹42.43 Cr as of 11th March 2025.What is the 52 week high and low of ANG Lifesciences India Ltd (ANG) share?
The 52-week high of ANG Lifesciences India Ltd (ANG) is ₹63.17 and the 52-week low is ₹29.85.What is the PE and PB ratio of ANG Lifesciences India Ltd (ANG) stock?
The P/E (price-to-earnings) ratio of ANG Lifesciences India Ltd (ANG) is -4.18. The P/B (price-to-book) ratio is 0.56.Which sector does ANG Lifesciences India Ltd (ANG) belong to?
ANG Lifesciences India Ltd (ANG) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy ANG Lifesciences India Ltd (ANG) shares?
You can directly buy ANG Lifesciences India Ltd (ANG) shares on Tickertape. Simply sign up, connect your demat account and place your order.
ANG Lifesciences India Ltd
ANGANG Lifesciences India Ltd
ANG
Health CarePharmaceuticals
SmallcapWith a market cap of ₹42 cr, stock is ranked 3,589
Moderate RiskStock is 2.93x as volatile as Nifty
31.891.85% (-0.60)
31.891.85% (-0.60)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -3.03 | 0.56 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 46.89 | 5.97 | 0.56% |
Forecast & Ratings
Detailed Forecast —
Forecast data is currently unavailable for this stockPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
ANG Lifesciences India is a pharmaceutical company, engaged in the business of manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials
Peers
Compare with peersSUNPHARMA
PE Ratio
40.38
1Y Return
1.12%
Buy Reco %
85.29
CIPLA
PE Ratio
28.66
1Y Return
2.75%
Buy Reco %
72.73
TORNTPHARM
PE Ratio
62.75
1Y Return
13.84%
Buy Reco %
68.00
DRREDDY
PE Ratio
16.73
1Y Return
12.31%
Buy Reco %
45.16
MANKIND
PE Ratio
48.73
1Y Return
4.48%
Buy Reco %
80.00
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
| Financial Year | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 154.93 | 355.20 | 229.61 | 146.81 | 115.41 | |||||
Raw Materials | 140.12 | 234.65 | 156.08 | 102.79 | 113.82 | |||||
| Power & Fuel Cost | 6.14 | 6.50 | 4.15 | |||||||
| Employee Cost | 21.29 | 23.97 | 19.35 | |||||||
| Selling & Administrative Expenses | 18.70 | 15.49 | 12.85 | |||||||
| Operating & Other expenses | 5.62 | 3.12 | -1.39 | |||||||
EBITDA | 14.81 | 68.80 | 24.45 | 9.06 | 1.59 | |||||
| Depreciation/Amortization | 1.33 | 5.88 | 9.35 | 8.37 | 7.38 | |||||
| PBIT | 13.48 | 62.92 | 15.10 | 0.69 | -5.79 | |||||
| Interest & Other Items | 3.52 | 9.42 | 12.48 | 11.41 | 10.10 | |||||
| PBT | 9.96 | 53.50 | 2.62 | -10.72 | -15.89 | |||||
| Taxes & Other Items | 3.11 | 13.19 | 2.89 | -0.57 | -1.89 | |||||
| Net Income | 6.85 | 40.31 | -0.27 | -10.15 | -14.00 | |||||
| EPS | 4.74 | 31.11 | -0.21 | -7.77 | -10.72 | |||||
| DPS | — | 0.80 | 0.00 | 0.00 | 0.00 | |||||
| Payout ratio | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 |
Company Updates
Peers & Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| ANG Lifesciences India Ltd | -4.18 | 0.56 | — |
| Sun Pharmaceutical Industries Ltd | 40.38 | 5.76 | 0.84% |
| Cipla Ltd | 28.66 | 4.41 | 0.89% |
| Torrent Pharmaceuticals Ltd | 62.75 | 15.16 | 0.91% |
Price Comparison
Compare ANG with any stock or ETFCompare ANG with any stock or ETF
ANG
Shareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateNov 2, 2021
Interim
Interim | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Nov 2, 2021
News & Opinions
Articles & Videos
Earnings
ANG Lifesciences India reports consolidated net loss of Rs 5.19 crore in the December 2024 quarter
Net Loss of ANG Lifesciences India reported to Rs 5.19 crore in the quarter ended December 2024 as against net loss of Rs 5.93 crore during the previous quarter ended December 2023. Sales rose 33.32% to Rs 24.73 crore in the quarter ended December 2024 as against Rs 18.55 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales24.7318.55 33 OPM %-8.69-10.30 - PBDT-4.42-4.45 1 PBT-6.38-6.37 0 NP-5.19-5.93 12 Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
ANG Lifesciences India schedules board meeting
ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
ANG Lifesciences India reports consolidated net loss of Rs 2.09 crore in the September 2024 quarter
Net Loss of ANG Lifesciences India reported to Rs 2.09 crore in the quarter ended September 2024 as against net loss of Rs 2.32 crore during the previous quarter ended September 2023. Sales declined 1.14% to Rs 32.88 crore in the quarter ended September 2024 as against Rs 33.26 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales32.8833.26 -1 OPM %6.964.99 - PBDT0.45-0.41 LP PBT-1.29-2.63 51 NP-2.09-2.32 10 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
ANG Lifesciences India to conduct board meeting
ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
ANG Lifesciences India to hold AGM
ANG Lifesciences India announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
ANG Lifesciences India to convene AGM
ANG Lifesciences India announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
ANG Lifesciences India reports consolidated net loss of Rs 3.07 crore in the June 2024 quarter
Net loss of ANG Lifesciences India reported to Rs 3.07 crore in the quarter ended June 2024 as against net profit of Rs 1.75 crore during the previous quarter ended June 2023. Sales declined 67.39% to Rs 18.41 crore in the quarter ended June 2024 as against Rs 56.46 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales18.4156.46 -67 OPM %-9.2311.58 - PBDT-2.514.55 PL PBT-4.142.36 PL NP-3.071.75 PL Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
ANG Lifesciences India to discuss results
ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live
6 months agoCapital Market - Live
North Eastern Carrying Corporation Ltd leads losers in ‘B’ group
1 year agoBusiness Standard
Alps Industries Ltd leads losers in ‘B’ group
2 years agoBusiness Standard
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
High Pledged Promoter Holding
A significant proportion of promoter holdings is pledged